Our verdict is Uncertain significance. The variant received 2 ACMG points: 3P and 1B. PM2PP3BP6
The NM_000368.5(TSC1):āc.826T>Cā(p.Ser276Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,461,892 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S276F) has been classified as Uncertain significance.
TSC1 (HGNC:12362): (TSC complex subunit 1) This gene is a tumor suppressor gene that encodes the growth inhibitory protein hamartin. The encoded protein interacts with and stabilizes the GTPase activating protein tuberin. This hamartin-tuberin complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. This protein also functions as a co-chaperone for Hsp90 that inhibits its ATPase activity. This protein functions as a facilitator of Hsp90-mediated folding of kinase and non-kinase clients, including TSC2 and thereby preventing their ubiquitination and proteasomal degradation. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
TSC1 Gene-Disease associations (from GenCC):
tuberous sclerosis
Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
tuberous sclerosis 1
Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, PanelApp Australia, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
lung lymphangioleiomyomatosis
Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
tuberous sclerosis complex
Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.78
BP6
Variant 9-132912369-A-G is Benign according to our data. Variant chr9-132912369-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 567952.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
Loss of phosphorylation at S276 (P = 0.0795);.;Loss of phosphorylation at S276 (P = 0.0795);Loss of phosphorylation at S276 (P = 0.0795);Loss of phosphorylation at S276 (P = 0.0795);Loss of phosphorylation at S276 (P = 0.0795);Loss of phosphorylation at S276 (P = 0.0795);Loss of phosphorylation at S276 (P = 0.0795);Loss of phosphorylation at S276 (P = 0.0795);.;.;Loss of phosphorylation at S276 (P = 0.0795);Loss of phosphorylation at S276 (P = 0.0795);Loss of phosphorylation at S276 (P = 0.0795);Loss of phosphorylation at S276 (P = 0.0795);Loss of phosphorylation at S276 (P = 0.0795);.;Loss of phosphorylation at S276 (P = 0.0795);.;